Preparation of labeled aromatic amino acids via late-stage


Journal

Chemical communications (Cambridge, England)
ISSN: 1364-548X
Titre abrégé: Chem Commun (Camb)
Pays: England
ID NLM: 9610838

Informations de publication

Date de publication:
19 Aug 2020
Historique:
pubmed: 21 7 2020
medline: 21 7 2020
entrez: 21 7 2020
Statut: ppublish

Résumé

A general protocol for the preparation of 18F-labeled AAAs and α-methyl-AAAs applying alcohol-enhanced Cu-mediated radiofluorination of Bpin-substituted chiral complexes using Ni/Cu-BPX templates as double protecting groups is reported. The chiral auxiliaries are easily accessible from commercially available starting materials in a few synthetic steps. The versatility of the method was demonstrated by the high-yielding preparation of a series of [18F]F-AAAs and the successful implementation of the protocol into automated radiosynthesis modules.

Identifiants

pubmed: 32686800
doi: 10.1039/d0cc02223c
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9505-9508

Auteurs

Austin Craig (A)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany and Max Planck Institute for Metabolism Research, Gleueler Str. 50, 50931 Cologne, Germany.

Niklas Kolks (N)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

Elizaveta A Urusova (EA)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

Johannes Zischler (J)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

Melanie Brugger (M)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de.

Heike Endepols (H)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany and Department of Nuclear Medicine, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

Bernd Neumaier (B)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany and Max Planck Institute for Metabolism Research, Gleueler Str. 50, 50931 Cologne, Germany.

Boris D Zlatopolskiy (BD)

Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, INM-5 Nuclear Chemistry, 52425 Jülich, Germany. b.neumaier@fz-juelich.de and Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany and Max Planck Institute for Metabolism Research, Gleueler Str. 50, 50931 Cologne, Germany.

Classifications MeSH